BlackRock Inc. Increases Position in GRAIL, Inc. $GRAL

BlackRock Inc. boosted its holdings in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 20.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,577,075 shares of the company's stock after purchasing an additional 608,539 shares during the quarter. BlackRock Inc. owned approximately 8.33% of GRAIL worth $244,207,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Farallon Capital Management LLC grew its stake in GRAIL by 73.7% in the 4th quarter. Farallon Capital Management LLC now owns 2,342,684 shares of the company's stock valued at $200,510,000 after acquiring an additional 993,684 shares during the period. Baker BROS. Advisors LP boosted its holdings in GRAIL by 27.9% in the 4th quarter. Baker BROS. Advisors LP now owns 2,085,333 shares of the company's stock worth $178,484,000 after buying an additional 455,208 shares during the last quarter. Vanguard Group Inc. boosted its holdings in GRAIL by 9.0% in the 4th quarter. Vanguard Group Inc. now owns 1,980,783 shares of the company's stock worth $169,535,000 after buying an additional 163,790 shares during the last quarter. State Street Corp boosted its holdings in GRAIL by 38.8% in the 4th quarter. State Street Corp now owns 1,827,523 shares of the company's stock worth $156,418,000 after buying an additional 510,546 shares during the last quarter. Finally, Morgan Stanley increased its stake in GRAIL by 63.8% during the 4th quarter. Morgan Stanley now owns 1,511,687 shares of the company's stock worth $129,385,000 after buying an additional 588,647 shares in the last quarter.

GRAIL Price Performance

NASDAQ GRAL opened at $79.59 on Thursday. The stock has a market capitalization of $3.56 billion, a P/E ratio of -8.16 and a beta of 3.24. The firm's 50-day moving average is $70.23 and its two-hundred day moving average is $63.65. GRAIL, Inc. has a 12 month low of $30.82 and a 12 month high of $118.84.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported ($2.56) earnings per share for the quarter, beating analysts' consensus estimates of ($2.66) by $0.10. The business had revenue of $44.69 million during the quarter, compared to analysts' expectations of $42.39 million. GRAIL had a negative net margin of 236.95% and a negative return on equity of 15.88%. As a group, analysts anticipate that GRAIL, Inc. will post -10.41 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have commented on GRAL. Weiss Ratings reissued a "sell (d-)" rating on shares of GRAIL in a report on Friday, July 17th. Piper Sandler lifted their price target on GRAIL from $54.00 to $56.00 and gave the stock a "neutral" rating in a research note on Wednesday, May 6th. The Goldman Sachs Group began coverage on GRAIL in a research report on Friday, June 5th. They set a "neutral" rating and a $60.00 price target for the company. Robert W. Baird set a $70.00 price objective on GRAIL in a research note on Wednesday, May 6th. Finally, Wall Street Zen upgraded GRAIL from a "sell" rating to a "hold" rating in a report on Saturday, May 9th. Four investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $67.78.

Insider Transactions at GRAIL

In other GRAIL news, insider Andrew John Partridge sold 1,491 shares of the business's stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $61.08, for a total value of $91,070.28. Following the sale, the insider owned 163,738 shares of the company's stock, valued at $10,001,117.04. The trade was a 0.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.83% of the stock is currently owned by insiders.

GRAIL Profile

GRAIL, Inc NASDAQ: GRAL is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test. Leveraging advances in next-generation sequencing, cell-free DNA (cfDNA) analysis and machine learning, GRAIL has developed the Galleri™ test, which aims to identify more than 50 types of cancer at their earliest stages. The company's platform analyzes methylation patterns in circulating tumor DNA to pinpoint tumor presence and tissue of origin, enabling physicians to pursue timely diagnostic follow-up.

Founded in 2016 as a spin-out from Illumina, GRAIL established its headquarters in Menlo Park, California, with additional research and operations centers in the United Kingdom.

Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GRAIL, Inc. (NASDAQ:GRAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source